Literature DB >> 2033641

Dioxin bioaccumulation: key to a sound risk assessment methodology.

E Rifkin1, J LaKind.   

Abstract

Human exposure to many pollutants occurs primarily through the ingestion of contaminated fish. In order to protect human health, regulatory agencies set limits on the levels of pollutants entering water bodies from point sources, thereby limiting the amount of pollutants that may be accumulated by fish. The limits, in the form of water quality criteria, are designed to correlate the concentration of a pollutant in a water body (and therefore the concentration accumulated by a fish) to the risks to humans. This type of model provides a reasonable way of controlling pollutants from point sources if the assumptions used in the model are realistic. However, the risk assessment formula currently used for developing water quality criteria only considers those pollutants in the water column available to fish through bioconcentration across the gills (freely dissolved pollutants). For strongly hydrophobic pollutants like dioxin, an extremely small fraction of the total amount is freely dissolved; most dioxin is sorbed to organic matter and is ingested by fish. A new model for developing criteria is presented here that takes into account the environmental fate of dioxin (predominantly in the sorbed state in the environment) and that fish accumulate dioxin by ingestion, rather than bioconcentration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033641     DOI: 10.1080/15287399109531509

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  2 in total

1.  Erik Rifkin, PhD: Writer, Researcher, Patient, and Citizen Advocate.

Authors:  Jennifer Chang
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

Review 2.  Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer.

Authors:  Francisco Aguayo; Enrique Boccardo; Alejandro Corvalán; Gloria M Calaf; Rancés Blanco
Journal:  Infect Agent Cancer       Date:  2021-06-30       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.